Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03703635Unknown
Randomised, open-label trial (2 arms). Primary endpoint: Stroke or death within 30 days or ischemic stroke/revascularization beyond 30 days through 12 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03703635.